Bruker Historical Income Statement

BRKR Stock

USD 80.97 0.38 0.47%

Historical analysis of Bruker income statement accounts such as Total Revenue of 3.1 B, Gross Profit of 1.6 B or Other Operating Expenses of 2.6 B can show how well Bruker performed in making a profits. Evaluating Bruker income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bruker's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bruker latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bruker is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

About Bruker Income Statement Analysis

Bruker Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bruker shareholders. The income statement also shows Bruker investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bruker Income Statement Chart

Bruker Income Statement is one of the three primary financial statements used for reporting Bruker's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bruker revenue and expense. Bruker Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Bruker's Total Other Income Expense Net is relatively stable compared to the past year. As of 04/28/2024, Depreciation And Amortization is likely to grow to about 120.6 M, while Cost Of Revenue is likely to drop slightly above 737 M.

Total Revenue Gross Profit Other Operating Expenses Ebit Total Operating Expenses

Total Revenue

Total revenue comprises all receipts Bruker generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Bruker minus its cost of goods sold. It is profit before Bruker operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bruker. It is also known as Bruker overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Bruker's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Total Other Income Expense Net is relatively stable compared to the past year. As of 04/28/2024, Depreciation And Amortization is likely to grow to about 120.6 M, while Cost Of Revenue is likely to drop slightly above 737 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.2B	1.3B	1.5B	1.6B
Total Revenue	2.4B	2.5B	3.0B	3.1B

Gross Profit Total Revenue

Bruker income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Total Other Income Expense Net	Depreciation And Amortization	Selling General Administrative	Research Development	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Selling And Marketing Expenses	Minority Interest	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Non Recurring	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.75	0.69	0.76	0.57	0.61	0.65	0.71	-0.04	0.74	0.73	0.69	0.88	0.51	0.44	0.6	-0.59	-0.04	0.42	-0.38	0.46	-0.57	-0.49	-0.15	0.4	0.19
Total Revenue	0.75		0.99	1.0	0.91	0.93	0.93	0.99	0.5	0.86	1.0	0.98	0.77	0.9	0.86	0.82	-0.92	-0.42	0.65	-0.35	0.58	-0.49	-0.4	0.16	0.75	0.59
Gross Profit	0.69	0.99		0.97	0.95	0.96	0.97	0.99	0.57	0.88	0.99	0.98	0.71	0.95	0.92	0.85	-0.9	-0.5	0.72	-0.36	0.64	-0.51	-0.43	0.17	0.82	0.63
Other Operating Expenses	0.76	1.0	0.97		0.86	0.89	0.89	0.99	0.46	0.83	1.0	0.99	0.78	0.85	0.82	0.78	-0.92	-0.37	0.58	-0.34	0.52	-0.44	-0.34	0.18	0.7	0.57
Operating Income	0.57	0.91	0.95	0.86		1.0	0.99	0.89	0.63	0.87	0.9	0.87	0.59	0.99	0.96	0.88	-0.81	-0.61	0.85	-0.36	0.75	-0.63	-0.56	0.1	0.9	0.63
Ebit	0.61	0.93	0.96	0.89	1.0		1.0	0.91	0.61	0.89	0.92	0.89	0.62	0.98	0.96	0.88	-0.82	-0.6	0.84	-0.33	0.74	-0.64	-0.56	0.12	0.88	0.62
Ebitda	0.65	0.93	0.97	0.89	0.99	1.0		0.91	0.58	0.93	0.92	0.89	0.64	0.97	0.95	0.87	-0.8	-0.55	0.83	-0.36	0.74	-0.65	-0.57	0.07	0.88	0.6
Total Operating Expenses	0.71	0.99	0.99	0.99	0.89	0.91	0.91		0.54	0.83	1.0	1.0	0.74	0.89	0.87	0.8	-0.92	-0.43	0.62	-0.34	0.55	-0.42	-0.33	0.22	0.75	0.64
Total Other Income Expense Net	-0.04	0.5	0.57	0.46	0.63	0.61	0.58	0.54		0.42	0.52	0.54	0.01	0.73	0.77	0.48	-0.44	-0.57	0.48	-0.04	0.36	-0.22	-0.08	0.64	0.69	0.91
Depreciation And Amortization	0.74	0.86	0.88	0.83	0.87	0.89	0.93	0.83	0.42		0.85	0.81	0.64	0.85	0.82	0.78	-0.63	-0.33	0.74	-0.45	0.67	-0.63	-0.55	-0.11	0.82	0.48
Selling General Administrative	0.73	1.0	0.99	1.0	0.9	0.92	0.92	1.0	0.52	0.85		0.99	0.75	0.89	0.87	0.81	-0.92	-0.42	0.63	-0.33	0.56	-0.46	-0.36	0.19	0.75	0.62
Research Development	0.69	0.98	0.98	0.99	0.87	0.89	0.89	1.0	0.54	0.81	0.99		0.73	0.87	0.85	0.79	-0.92	-0.41	0.59	-0.37	0.52	-0.36	-0.29	0.22	0.74	0.64
Cost Of Revenue	0.88	0.77	0.71	0.78	0.59	0.62	0.64	0.74	0.01	0.64	0.75	0.73		0.53	0.48	0.59	-0.74	-0.12	0.54	-0.32	0.46	-0.45	-0.36	-0.13	0.5	0.29
Income Before Tax	0.51	0.9	0.95	0.85	0.99	0.98	0.97	0.89	0.73	0.85	0.89	0.87	0.53		0.99	0.85	-0.8	-0.64	0.83	-0.29	0.71	-0.58	-0.5	0.22	0.91	0.72
Net Income	0.44	0.86	0.92	0.82	0.96	0.96	0.95	0.87	0.77	0.82	0.87	0.85	0.48	0.99		0.76	-0.77	-0.64	0.83	-0.23	0.61	-0.57	-0.46	0.28	0.9	0.75
Income Tax Expense	0.6	0.82	0.85	0.78	0.88	0.88	0.87	0.8	0.48	0.78	0.81	0.79	0.59	0.85	0.76		-0.73	-0.54	0.65	-0.44	0.91	-0.51	-0.55	0.0	0.75	0.48
Selling And Marketing Expenses	-0.59	-0.92	-0.9	-0.92	-0.81	-0.82	-0.8	-0.92	-0.44	-0.63	-0.92	-0.92	-0.74	-0.8	-0.77	-0.73		0.43	-0.57	0.19	-0.48	0.35	0.26	-0.17	-0.65	-0.53
Minority Interest	-0.04	-0.42	-0.5	-0.37	-0.61	-0.6	-0.55	-0.43	-0.57	-0.33	-0.42	-0.41	-0.12	-0.64	-0.64	-0.54	0.43		-0.59	0.02	-0.51	0.13	0.17	-0.41	-0.57	-0.51
Net Income From Continuing Ops	0.42	0.65	0.72	0.58	0.85	0.84	0.83	0.62	0.48	0.74	0.63	0.59	0.54	0.83	0.83	0.65	-0.57	-0.59		-0.24	0.68	-0.67	-0.59	-0.08	0.89	0.52
Non Operating Income Net Other	-0.38	-0.35	-0.36	-0.34	-0.36	-0.33	-0.36	-0.34	-0.04	-0.45	-0.33	-0.37	-0.32	-0.29	-0.23	-0.44	0.19	0.02	-0.24		-0.4	0.17	0.07	0.23	-0.32	-0.07
Tax Provision	0.46	0.58	0.64	0.52	0.75	0.74	0.74	0.55	0.36	0.67	0.56	0.52	0.46	0.71	0.61	0.91	-0.48	-0.51	0.68	-0.4		-0.54	-0.61	-0.18	0.71	0.34
Non Recurring	-0.57	-0.49	-0.51	-0.44	-0.63	-0.64	-0.65	-0.42	-0.22	-0.63	-0.46	-0.36	-0.45	-0.58	-0.57	-0.51	0.35	0.13	-0.67	0.17	-0.54		0.83	0.18	-0.51	-0.24
Interest Income	-0.49	-0.4	-0.43	-0.34	-0.56	-0.56	-0.57	-0.33	-0.08	-0.55	-0.36	-0.29	-0.36	-0.5	-0.46	-0.55	0.26	0.17	-0.59	0.07	-0.61	0.83		0.31	-0.4	-0.05
Net Interest Income	-0.15	0.16	0.17	0.18	0.1	0.12	0.07	0.22	0.64	-0.11	0.19	0.22	-0.13	0.22	0.28	0.0	-0.17	-0.41	-0.08	0.23	-0.18	0.18	0.31		0.02	0.65
Reconciled Depreciation	0.4	0.75	0.82	0.7	0.9	0.88	0.88	0.75	0.69	0.82	0.75	0.74	0.5	0.91	0.9	0.75	-0.65	-0.57	0.89	-0.32	0.71	-0.51	-0.4	0.02		0.72
Extraordinary Items	0.19	0.59	0.63	0.57	0.63	0.62	0.6	0.64	0.91	0.48	0.62	0.64	0.29	0.72	0.75	0.48	-0.53	-0.51	0.52	-0.07	0.34	-0.24	-0.05	0.65	0.72

Click cells to compare fundamentals

Bruker Account Relationship Matchups

Bruker income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	12.6M	16M	14.4M	16.1M	16.4M	12.1M
Total Revenue	2.1B	2.0B	2.4B	2.5B	3.0B	3.1B
Gross Profit	995.3M	939.8M	1.2B	1.3B	1.5B	1.6B
Other Operating Expenses	1.8B	1.7B	2.0B	2.1B	2.5B	2.6B
Operating Income	300.9M	248.3M	413.3M	432.7M	482.3M	506.4M
Ebit	300.9M	248.3M	413.3M	432.7M	482.3M	506.4M
Ebitda	383M	353.6M	516.7M	550.4M	597.2M	627.1M
Total Operating Expenses	687.9M	666.6M	782M	843.3M	1.0B	1.1B
Total Other Income Expense Net	(19.5M)	(20.5M)	(22.5M)	(18.8M)	61.9M	65.0M
Depreciation And Amortization	82.1M	105.3M	103.4M	117.7M	114.9M	120.6M
Selling General Administrative	500.2M	477.8M	564.5M	610.8M	730.1M	766.6M
Research Development	187.7M	198M	220.8M	235.9M	294.8M	309.5M
Cost Of Revenue	1.1B	1.0B	1.2B	1.2B	1.4B	737.0M
Income Before Tax	280.4M	225.8M	393.6M	413.9M	544.2M	571.4M
Net Income	197.2M	157.8M	277.1M	296.6M	427.2M	448.6M
Income Tax Expense	82.4M	64.4M	113M	116.4M	117.7M	123.6M
Net Income Applicable To Common Shares	197.2M	157.8M	277.1M	296.6M	341.1M	358.1M
Minority Interest	800K	7.6M	(3.5M)	(1.9M)	(3.1M)	(2.9M)
Net Income From Continuing Ops	198M	168.9M	280.6M	298.5M	322.2M	185.6M
Non Operating Income Net Other	(20.5M)	(22.5M)	(19.7M)	(18.8M)	(16.9M)	(17.8M)
Tax Provision	82.4M	64.4M	113M	116.4M	104M	82.4M
Interest Income	1.3M	3.2M	900K	4.1M	7.7M	8.1M
Net Interest Income	(14.7M)	(22.5M)	(19.7M)	(18.8M)	(6.4M)	(6.7M)
Reconciled Depreciation	75.6M	80.4M	89.1M	88M	102.1M	88.6M

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

0.89	A	Agilent Technologies Financial Report 28th of May 2024	Pair Corr
0.83	ELEV	Elevation Oncology Earnings Call This Week	Pair Corr
0.61	ENVB	Enveric Biosciences Financial Report 20th of May 2024	Pair Corr

The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.

The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bruker is a strong investment it is important to analyze Bruker's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bruker's future performance. For an informed investment choice regarding Bruker Stock, refer to the following important reports:

How To Invest In Bruker

Details

Is Bruker Stock a good investment?

Details

What is Bruker's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Bruker Stock analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.

	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Volatility Analysis Get historical volatility and risk analysis based on latest market data

Is Bruker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bruker. If investors know Bruker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bruker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.127

Dividend Share

0.2

Earnings Share

2.9

Revenue Per Share

20.249

Quarterly Revenue Growth

0.206

The market value of Bruker is measured differently than its book value, which is the value of Bruker that is recorded on the company's balance sheet. Investors also form their own opinion of Bruker's value that differs from its market value or its book value, called intrinsic value, which is Bruker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bruker's market value can be influenced by many factors that don't directly affect Bruker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bruker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bruker Historical Income Statement

About Bruker Income Statement Analysis

Bruker Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Total Operating Expenses

Bruker income statement Correlations

Bruker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bruker income statement Accounts

Pair Trading with Bruker

Moving together with Bruker Stock

Complementary Tools for Bruker Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Selling General Administrative	+ 1.0	Total Revenue
Selling General Administrative	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Selling General Administrative	+ 1.0	Total Operating Expenses

Selling And Marketing Expenses	- 0.92	Research Development
Selling And Marketing Expenses	- 0.92	Selling General Administrative
Selling And Marketing Expenses	- 0.92	Total Operating Expenses
Selling And Marketing Expenses	- 0.92	Other Operating Expenses
Selling And Marketing Expenses	- 0.92	Total Revenue
Selling And Marketing Expenses	- 0.9	Gross Profit